Novo Nordisk's pricing techniques inside the U.S. have drawn sharp criticism from lawmakers like Senator Sanders, who has accused the company of price gouging, mentioning the stark distinction among U.S. prices and people in Europe and copyright.This led Novo Nordisk to carry out even more research into larger dosages of semaglutide especially for